JPS4950124A - - Google Patents
Info
- Publication number
- JPS4950124A JPS4950124A JP9685072A JP9685072A JPS4950124A JP S4950124 A JPS4950124 A JP S4950124A JP 9685072 A JP9685072 A JP 9685072A JP 9685072 A JP9685072 A JP 9685072A JP S4950124 A JPS4950124 A JP S4950124A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9685072A JPS4950124A (zh) | 1972-09-27 | 1972-09-27 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9685072A JPS4950124A (zh) | 1972-09-27 | 1972-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS4950124A true JPS4950124A (zh) | 1974-05-15 |
Family
ID=14175957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9685072A Pending JPS4950124A (zh) | 1972-09-27 | 1972-09-27 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS4950124A (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5716818A (en) * | 1981-04-25 | 1982-01-28 | Green Cross Corp:The | Steroid fatty emulsion |
JPS5859912A (ja) * | 1981-10-06 | 1983-04-09 | Green Cross Corp:The | 鎮痛消炎物質脂肪乳剤 |
JPS58162517A (ja) * | 1982-03-19 | 1983-09-27 | Green Cross Corp:The | 脂溶性ビタミン含有脂肪乳剤 |
JPS5913720A (ja) * | 1982-07-15 | 1984-01-24 | Green Cross Corp:The | フルルビプロフエン脂肪乳剤 |
EP0100459A2 (en) * | 1982-07-07 | 1984-02-15 | Eisai Co., Ltd. | An aqueous liquid containing a fat-soluble substance |
JPS59141518A (ja) * | 1983-02-03 | 1984-08-14 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
JPS59216820A (ja) * | 1983-05-20 | 1984-12-06 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
JPS6051104A (ja) * | 1983-08-30 | 1985-03-22 | Ajinomoto Co Inc | ビタミンe含有水性液剤 |
JPS6117512A (ja) * | 1984-07-03 | 1986-01-25 | Ss Pharmaceut Co Ltd | 低溶血性ビタミンe注射液 |
JP2002532564A (ja) * | 1998-12-21 | 2002-10-02 | フレセニウス・カビ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 過酸化によるヒト臓器への損傷に対して保護作用を有する水中油型エマルジョン、その製造及び使用 |
EP1842567A3 (en) * | 2001-11-08 | 2008-01-02 | Atrium Medical Corporation | Intraluminal device with a coating containing a therapeutic agent |
US10772995B2 (en) | 2004-09-28 | 2020-09-15 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US10792312B2 (en) | 2004-09-28 | 2020-10-06 | Atrium Medical Corporation | Barrier layer |
US10814043B2 (en) | 2004-09-28 | 2020-10-27 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US10864304B2 (en) | 2009-08-11 | 2020-12-15 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US10888617B2 (en) | 2012-06-13 | 2021-01-12 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US11083823B2 (en) | 2005-09-28 | 2021-08-10 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US11097035B2 (en) | 2010-07-16 | 2021-08-24 | Atrium Medical Corporation | Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
US11166929B2 (en) | 2009-03-10 | 2021-11-09 | Atrium Medical Corporation | Fatty-acid based particles |
-
1972
- 1972-09-27 JP JP9685072A patent/JPS4950124A/ja active Pending
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5716818A (en) * | 1981-04-25 | 1982-01-28 | Green Cross Corp:The | Steroid fatty emulsion |
JPH0128727B2 (zh) * | 1981-04-25 | 1989-06-05 | Green Cross Corp | |
JPH0139406B2 (zh) * | 1981-10-06 | 1989-08-21 | Green Cross Corp | |
JPS5859912A (ja) * | 1981-10-06 | 1983-04-09 | Green Cross Corp:The | 鎮痛消炎物質脂肪乳剤 |
JPS58162517A (ja) * | 1982-03-19 | 1983-09-27 | Green Cross Corp:The | 脂溶性ビタミン含有脂肪乳剤 |
JPH0145446B2 (zh) * | 1982-03-19 | 1989-10-03 | Green Cross Corp | |
EP0100459A2 (en) * | 1982-07-07 | 1984-02-15 | Eisai Co., Ltd. | An aqueous liquid containing a fat-soluble substance |
JPS5913720A (ja) * | 1982-07-15 | 1984-01-24 | Green Cross Corp:The | フルルビプロフエン脂肪乳剤 |
JPH0138767B2 (zh) * | 1982-07-15 | 1989-08-16 | Midori Juji Kk | |
JPS59141518A (ja) * | 1983-02-03 | 1984-08-14 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
JPH0157095B2 (zh) * | 1983-02-03 | 1989-12-04 | Taisho Seiyaku Kk | |
JPS59216820A (ja) * | 1983-05-20 | 1984-12-06 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
JPH0157096B2 (zh) * | 1983-05-20 | 1989-12-04 | Taisho Seiyaku Kk | |
JPS6051104A (ja) * | 1983-08-30 | 1985-03-22 | Ajinomoto Co Inc | ビタミンe含有水性液剤 |
JPH0521885B2 (zh) * | 1983-08-30 | 1993-03-25 | Ajinomoto Kk | |
JPS6117512A (ja) * | 1984-07-03 | 1986-01-25 | Ss Pharmaceut Co Ltd | 低溶血性ビタミンe注射液 |
JP2002532564A (ja) * | 1998-12-21 | 2002-10-02 | フレセニウス・カビ・オーストリア・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 過酸化によるヒト臓器への損傷に対して保護作用を有する水中油型エマルジョン、その製造及び使用 |
EP1842567A3 (en) * | 2001-11-08 | 2008-01-02 | Atrium Medical Corporation | Intraluminal device with a coating containing a therapeutic agent |
US10772995B2 (en) | 2004-09-28 | 2020-09-15 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US10792312B2 (en) | 2004-09-28 | 2020-10-06 | Atrium Medical Corporation | Barrier layer |
US10814043B2 (en) | 2004-09-28 | 2020-10-27 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US10869902B2 (en) | 2004-09-28 | 2020-12-22 | Atrium Medical Corporation | Cured gel and method of making |
US11083823B2 (en) | 2005-09-28 | 2021-08-10 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US11166929B2 (en) | 2009-03-10 | 2021-11-09 | Atrium Medical Corporation | Fatty-acid based particles |
US10864304B2 (en) | 2009-08-11 | 2020-12-15 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US11097035B2 (en) | 2010-07-16 | 2021-08-24 | Atrium Medical Corporation | Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
US10888617B2 (en) | 2012-06-13 | 2021-01-12 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |